FORWARD FEATURES CALENDAR

Deals

BaltCap invests in pan-Baltic laboratory supplier Labochema

Lithuania SME Fund managed by BaltCap has completed a growth capital investment in Labochema, a leading pan-Baltic laboratory supply provider. This is the third investment made by BaltCap’s Lithuania SME Fund.  Labochema (consisting of Labochema LT, Labochema Latvija and Labochema Eesti) is the leading provider of laboratory supplies and related

High Street Capital completes sale of Massey Fair

High Street Capital has sold its interest in Mac & Massey (Massey Fair) to Batory Foods, Inc. With branch locations across the continental US, Massey sources and distributes food ingredients for food manufacturers nationwide. Massey’s customers range from local niche, specialty food manufacturers to the Fortune 500. Massey’s management team

Albion Ventures invests to back a GBP5 million MBO of Hilson Moran

Albion Ventures has invested in Hilson Moran Holdings Limited to enable the staff of Hilson Moran Partnership Limited (Hilson Moran), an engineering and environmental consultancy, to carry out a GBP5 million MBO and gain independence from the UK subsidiary of Altran Technologies. Hilson Moran provides consultancy in building services, sustainability,

UK’s EIIB takes strategic stake in Rasmala

EIIB has completed an investment in Rasmala Holdings Limited, an investment bank operating in the Gulf Cooperation Council (GCC) countries and Egypt specialising in asset management, investment banking, brokerage and research. Rasmala was one of the first regional investment banks to be licensed by the Dubai Financial Services Authority with

The Jordan Company acquires Vantage Specialty Chemicals

The Resolute Fund II, LP, an affiliate of The Jordan Company, has acquired Vantage Specialty Chemicals from HIG Capital. Financial terms of the transaction have not been disclosed.   Headquartered in Chicago, Illinois, Vantage is a diversified specialty chemicals producer focused on naturally derived ingredients. The Company supplies more than

GBP1.75M investment for Manchester University spin-out

Award-winning medical technology spin-out company, Ai2 Limited has secured GBP1.75M in a joint investment from managers of the North West Fund for Biomedical, SPARK Impact and MTI Firms, managers of UMIP Premier Fund. The deal, which saw MTI invest GBP950k and SPARK Impact, invest GBP800k, allows the Manchester University spin-out

AAIPharma Services acquires Celsis Analytical Services

AAIPharma Services Corp has acquired Celsis Analytical Services, a division of Celsis International Ltd that performs material testing services for the pharmaceutical, biotechnology and manufacturing sectors. “The addition of Celsis Analytical Services will enable AAIPharma to expand its market presence in two key regions. Our combined company will bring a

Events

12 November, 2026 – 5:00 pm

Directory Listings